Sign in

CIK 0001125345

  • Non-accelerated filer
  • Smaller reporting company

MACROGENICS INC

Sign in to watch
Ticker
MGNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 301-251-5172
Business address
9704 MEDICAL CENTER DRIVE, Rockville, MD, 20850
  1. 4 Exercise or conversion SVP, CFO and Secretary acquired 6,000 shares (option exercise)
  2. 4 Open-market sale Sr VP & Chief Business Officer sold 500 shares at $24.10 ($12,050)
  3. 4 Open-market sale Sr VP & Chief Business Officer sold 500 shares at $23.35 ($11,675)
  4. 4 Open-market sale Sr VP & Chief Business Officer sold 1,500 shares at $20.69 ($31,035)
  5. 4 Open-market sale Sr VP & Chief Business Officer sold 500 shares at $25.33 ($12,665)
  6. 4 Open-market sale Sr VP, Research & CSO sold 62,851 shares at an average $30.50 ($1,916,867)
  7. 4 Open-market sale Director sold 20,773 shares at $27.11 ($563,156)
  8. 4 Open-market sale Sr VP & Chief Business Officer sold 500 shares at $27.10 ($13,550)
  9. 4 Insider Changes in Ownership
  10. 4 Insider Changes in Ownership
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market sale Sr VP & Chief Business Officer sold 500 shares at $28.49 ($14,245)
  16. 4 Open-market sale Sr VP & Chief Business Officer sold 500 shares at $26.59 ($13,295)
  17. 4 Open-market sale Sr VP, BPD & Manufacturing sold 7,500 shares at $25.30 ($189,750)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 11 of 25 · 484 filings